Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.9199
-0.0439 (-4.55%)
At close: Aug 1, 2025, 4:00 PM
0.9206
+0.0007 (0.08%)
After-hours: Aug 1, 2025, 5:09 PM EDT
Klotho Neurosciences Market Cap
Klotho Neurosciences has a market cap or net worth of $48.49 million as of August 1, 2025. Its market cap has increased by 91.89% in one year.
Market Cap
48.49M
Enterprise Value
49.74M
1-Year Change
91.89%
Ranking
Category
Stock Price
0.92
Market Cap Chart
Since April 29, 2022, Klotho Neurosciences's market cap has decreased from $127.33M to $48.49M, a decrease of -61.92%. That is a compound annual growth rate of -25.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 50.80M | 392.55% |
| Dec 31, 2024 | 10.31M | -89.05% |
| Dec 22, 2023 | 94.18M | -37.22% |
| Dec 20, 2022 | 150.02M | 17.82% |
| Apr 29, 2022 | 127.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.45B |
| Johnson & Johnson | 405.44B |
| AbbVie | 336.85B |
| UnitedHealth Group | 239.76B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 225.13B |
| Novo Nordisk | 221.96B |